Chapter 63 The future of stroke prevention by risk factor modification

作者: Philip B. Gorelick

DOI: 10.1016/S0072-9752(08)94063-X

关键词:

摘要: Publisher Summary Future stroke prevention promises to open up new avenues for risk reduction. Stroke is ideally suited as it characterized by a high prevalence of disease, substantial number modifiable factors, therapies that have proven reduce risk, rate disability, and economic burden. Observational epidemiological studies led the identification factors stroke, clinical trials established robust armamentarium preventions first or recurrent stroke. undergoing transformation. The chapter discusses traditional approaches prevention, screening methods future those at cardiovascular disease impact these on reduction, novel how they may organization care, preventive services.

参考文章(131)
R. Brian Haynes, Amit X. Garg, Heather P. McDonald, Helping Patients Follow Prescribed Treatment ,(2002)
Hofman Kj, Yach D, Hawkes C, Gould L, The global burden of chronic diseases. JAMA. ,vol. 291, ,(2004)
David L Sackett, R Brian Haynes, Peter Tugwell, Clinical Epidemiology: A Basic Science for Clinical Medicine ,(1991)
K A Jellinger, Drug Therapy for Stroke Prevention European Journal of Neurology. ,vol. 9, pp. 120- 121 ,(2002) , 10.1046/J.1468-1331.2002.0312C.X
Eric Boersma, Nestor Mercado, Don Poldermans, Martin Gardien, Jeroen Vos, Maarten L Simoons, Acute myocardial infardion The Lancet. ,vol. 361, pp. 847- 858 ,(2003) , 10.1016/S0140-6736(03)12712-2